Biokin Pharmaceutical (2615 HK)

Biokin Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and supply of biomedicine. It specializes in large-molecule oncology therapeutics, including antibody drug conjugates (ADCs), multi-specific antibodies, and antibody radionuclide conjugates (ARCs), alongside offerings in anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines. The company was founded in 1996 and is headquartered in Chengdu, China.